These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6733020)

  • 21. Direct inhibitory effect of a luteinizing hormone-releasing hormone agonist on MCF-7 human breast cancer cells.
    Blankenstein MA; Henkelman MS; Klijn JG
    Eur J Cancer Clin Oncol; 1985 Dec; 21(12):1493-9. PubMed ID: 3938397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: growth stimulation in the presence of tamoxifen.
    Boylan M; van den Berg HW; Lynch M
    Ann Oncol; 1998 Feb; 9(2):205-11. PubMed ID: 9553667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indole-3-carbinol and tamoxifen cooperate to arrest the cell cycle of MCF-7 human breast cancer cells.
    Cover CM; Hsieh SJ; Cram EJ; Hong C; Riby JE; Bjeldanes LF; Firestone GL
    Cancer Res; 1999 Mar; 59(6):1244-51. PubMed ID: 10096555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of tamoxifen on the receptor-positive T61 and the receptor-negative T60 human breast carcinomas grown in nude mice.
    Brünner N; Spang-Thomsen M; Vindeløv L; Wolff J; Engelholm SA
    Eur J Cancer Clin Oncol; 1985 Nov; 21(11):1349-54. PubMed ID: 4076295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro.
    Reddel RR; Sutherland RL
    Cancer Res; 1987 Oct; 47(20):5323-9. PubMed ID: 3652038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
    van den Berg HW; Martin J; Lynch M
    Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors affecting the sensitivity of T-47D human breast cancer cells to tamoxifen.
    Reddel RR; Murphy LC; Sutherland RL
    Cancer Res; 1984 Jun; 44(6):2398-405. PubMed ID: 6722780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of 4-hydroxytamoxifen and a novel pure antioestrogen (ICI 182780) on the clonogenic growth of human breast cancer cells in vitro.
    DeFriend DJ; Anderson E; Bell J; Wilks DP; West CM; Mansel RE; Howell A
    Br J Cancer; 1994 Aug; 70(2):204-11. PubMed ID: 8054267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cell cycle effects of antiestrogens and medroxyprogesterone acetate on the MCF-7 human breast cancer cell line].
    Ikeda T; Enomoto K; Fujiwara K; Koh J; Ishii S; Fukutomi T; Nakamura A; Abe O; Tsuru S; Jinnaka H
    Nihon Gan Chiryo Gakkai Shi; 1985 Dec; 20(10):2243-50. PubMed ID: 2937861
    [No Abstract]   [Full Text] [Related]  

  • 30. Parathyroid hormone-related protein secretion is inhibited by oestradiol and stimulated by antioestrogens in KPL-3C human breast cancer cells.
    Kurebayashi J; Sonoo H
    Br J Cancer; 1997; 75(12):1819-25. PubMed ID: 9192988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of estrogen and antiestrogen on the human breast cancer cell line MCF-7 adapted to growth at low serum concentration.
    Briand P; Lykkesfeldt AE
    Cancer Res; 1984 Mar; 44(3):1114-9. PubMed ID: 6362856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of melatonin on the cell cycle kinetics and "estrogen-rescue" of MCF-7 human breast cancer cells in culture.
    Cos S; Blask DE; Lemus-Wilson A; Hill AB
    J Pineal Res; 1991 Jan; 10(1):36-42. PubMed ID: 2056430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Points of action of estrogen antagonists and a calmodulin antagonist within the MCF-7 human breast cancer cell cycle.
    Musgrove EA; Wakeling AE; Sutherland RL
    Cancer Res; 1989 May; 49(9):2398-404. PubMed ID: 2706627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of cyclopropyl antiestrogens on the cell cycle kinetics of MCF-7 human breast cancer cells.
    Jain PT; Pento JT; Magarian RA
    Anticancer Res; 1995; 15(6B):2529-32. PubMed ID: 8669818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. WBP2 modulates G1/S transition in ER+ breast cancer cells and is a direct target of miR-206.
    Ren YQ; Wang HJ; Zhang YQ; Liu YB
    Cancer Chemother Pharmacol; 2017 May; 79(5):1003-1011. PubMed ID: 28391353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of alpha-interferon, 17 beta-estradiol, and tamoxifen on estrogen receptor concentration and cell cycle kinetics of MCF 7 cells.
    Bezwoda WR; Meyer K
    Cancer Res; 1990 Sep; 50(17):5387-91. PubMed ID: 2386944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aurora kinase B is important for antiestrogen resistant cell growth and a potential biomarker for tamoxifen resistant breast cancer.
    Larsen SL; Yde CW; Laenkholm AV; Rasmussen BB; Duun-Henriksen AK; Bak M; Lykkesfeldt AE; Kirkegaard T
    BMC Cancer; 2015 Apr; 15():239. PubMed ID: 25885472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of tamoxifen and the derivative (TAT) on cell cycle of MCF-7 in vitro.
    Tominaga T; Yoshida Y; Matsumoto A; Hayashi K; Kosaki G
    Anticancer Res; 1993; 13(3):661-5. PubMed ID: 8317894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitation of G0 and G1 phase cells in primary carcinomas. Antibody to M1 subunit of ribonucleotide reductase shows G1 phase restriction point block.
    Tay DL; Bhathal PS; Fox RM
    J Clin Invest; 1991 Feb; 87(2):519-27. PubMed ID: 1991836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Urothelial carcinoma-associated 1 enhances tamoxifen resistance in breast cancer cells through competitively inhibiting miR-18a].
    Li XN; Liu AH; Tang X; Ren Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Apr; 49(2):295-302. PubMed ID: 28416841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.